1.
van de Kerkhof P, Pinter A, Boehnlein M, Kavanagh S, Crowley J. Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. J of Skin [Internet]. 2019Nov.9 [cited 2022Sep.25];3:S40. Available from: https://jofskin.org/index.php/skin/article/view/767